Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:4.6.1.2 (
guanylate cyclase
)
8,497
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Platelet activating factor (PAF) treatment caused a transient rise in cyclic GMP levels in rat hippocampal slices. The stimulation of cyclic GMP synthesis induced by PAF was dose-dependent and was suppressed after treatment with
PCA
-4248, a PAF antagonist, a fact that could suggest the involvement of specific PAF receptors. In addition, when slices were incubated in the presence of N-nitro-L-arginine, a nitric oxide (NO) synthase inhibitor, PAF-stimulated cyclic GMP generation was abolished. Therefore, PAF activates
guanylyl cyclase
most probably via formation of NO. PAF also induced a time-dependent increase of NO synthase activity in hippocampal slices in correlation with the increase observed in cyclic GMP levels.
...
PMID:Nitric oxide mediates the PAF-stimulated cyclic GMP production in hippocampal slices. 880 87